Macrotroponin interference and association with cardiotoxicity in patients receiving cardiotoxic breast cancer therapy: a pilot study

Macrotroponin interference and association with cardiotoxicity in patients receiving cardiotoxic breast cancer therapy: a pilot study

Abstract Background Cancer therapy-related cardiac dysfunction (CTRCD) is an important adverse effect in patients receiving potential cardiotoxic cancer therapies. Interpretation of cardiac troponin results can be affected by presence of macrotroponin, which can complicate CTRCD assessment. We aimed...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrea Soosaipillai, Inbar Nardi-Agmon, Davor Brinc, Anselmo Fabros, Peter A. Kavsak, Paaladinesh Thavendiranathan, Ashley Di Meo
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Cardio-Oncology
Subjects:
ERBB2 + breast cancer
Trastuzumab
Herceptin
Anthracycline
Myocardial injury
Cardiac troponin
Online Access:https://doi.org/10.1186/s40959-025-00314-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40959-025-00314-9

Similar Items